Fibrinogen alpha chain (FGA) Goat Polyclonal Antibody
CAT#: TA319311
Goat polyclonal anti-Fibrinogen antibody
Need it in bulk or conjugated?
Get a free quote
CNY 8025.00
货期*
5周
规格
推荐一起购买 (2)
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | ELISA: 1:20,000 - 1:100,000, WB: 1:2,000 - 1:10,000 |
Reactivity | Human |
Host | Goat |
Clonality | Polyclonal |
Immunogen | Fibrinogen [Human Plasma] |
Formulation | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Gene Name | fibrinogen alpha chain |
Database Link | |
Synonyms | Fib2 |
Note | Fibrinogen (factor I) is a soluble plasma glycoprotein, synthesised by the liver, that is converted by thrombin into fibrin during blood coagulation. This is achieved through processes in the coagulation cascade that activate the zymogen prothrombin to the serine protease thrombin, which is responsible for converting fibrinogen into fibrin. Fibrin is then cross linked by factor XIII to form a clot. FXIIIa stabilizes fibrin further by incorporation of the fibrinolysis inhibitors alpha-2-antiplasmin and TAFI (thrombin activatable fibrinolysis inhibitor, procarboxypeptidase B), and binding to several adhesive proteins of various cells. Both the activation of Factor XIII by thrombin and plasminogen activator (t-PA) are catalyzed by fibrin. Fibrin specifically binds the activated coagulation factors factor Xa and thrombin and entraps them in the network of fibers, thus functioning as a temporary inhibitor of these enzymes, which stay active and can be released during fibrinolysis. Recent research has shown that fibrin plays a key role in the inflammatory response. Anti-Fibrinogen (Human Plasma) is ideal for Serum Protein Component research. |
Reference Data | |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Complement and coagulation cascades |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它Fibrinogen alpha chain产品
Customer
Reviews
Loading...